{
    "title": "109_s1128",
    "content": "The Act may be cited as the \"Pharmaceutical Advertising and Prudent Purchasing Act\" and includes increased rebates under the Medicaid program for prescription drugs directly advertised to consumers. The \"Pharmaceutical Advertising and Prudent Purchasing Act\" amends Section 1927(b) of the Social Security Act to increase rebates for covered outpatient drugs directly advertised to consumers under the Medicaid program. Manufacturers must certify to the Secretary if their drug was not directly advertised to consumers to avoid the rebate increase. The Secretary will adjust the rebate formula for covered outpatient drugs advertised directly to consumers under Medicaid, considering factors like average manufacturer price and best price. The amendment requires the Secretary to consider increased costs from purchasing drugs advertised directly to consumers and consult with manufacturers. Directly advertised to consumers means ads through various media. Effective date of the amendment applies to. The amendment made by this section applies to rebate agreements under the Social Security Act entered into or renewed 180 days after the enactment of this Act. Reduced payment and reimbursement mechanisms for federal programs purchasing or providing reimbursement for prescription drugs directly advertised to consumers. The Secretary of Health and Human Services and the Secretary of Veterans Affairs must develop procedures for federal agencies to pay a reduced price for drugs not directly advertised to consumers. The subsection describes health-related programs under the Public Health Service, Department of Veterans Affairs, and Department of Defense. Definitions for \"covered drug\" and \"covered outpatient drug\" are provided. The term \"drug\" is defined in relation to the Social Security Act. \"Directly advertised to consumers\" refers to ads for covered drugs disseminated through various media. The term \"manufacturer\" is defined in specific code sections. Conforming amendments are made regarding prescription drugs purchased by covered entities under agreements. Section 340B(a) of the Public Health Service Act is amended to include a provision for reduced negotiated prices for covered drugs advertised directly to consumers. The agreement must ensure that the price charged for each covered drug purchased by a covered entity does not exceed the reduced negotiated price. The Pharmaceutical Advertising and Prudent Purchasing Act requires drug manufacturers to certify to the Secretary that their drugs were not directly advertised to consumers in the previous 12 months. This applies to procurement of prescription drugs by various government departments and agencies. The Pharmaceutical Advertising and Prudent Purchasing Act requires drug manufacturers to certify that their drugs were not directly advertised to consumers in the previous 12 months. Section 8126 of title 38, United States Code, is amended to include provisions for covered drugs procured by Federal agencies under depot contracting systems or national contracts entered into by the Secretary. The Pharmaceutical Advertising and Prudent Purchasing Act requires drug manufacturers to certify that their drugs were not directly advertised to consumers in the previous 12 months. Section 8126 of title 38, United States Code, is amended to include provisions for covered drugs procured by Federal agencies under depot contracting systems or national contracts entered into by the Secretary, limiting the price charged for drugs that were directly advertised to consumers. The amendments made by this section apply to master agreements, pricing agreements, and contracts entered into or renewed on or after the date that is 180 days after the date of enactment of this Act. REPORT TO CONGRESS ON STRATEGIES TO REDUCE COST OF PRESCRIPTION DRUGS COVERED UNDER MEDICARE AND FEDERAL PROGRAMS ADVERTISED TO CONSUMERS. The Secretary of Health and Human Services, in consultation with the Secretary of Veterans Affairs, must submit a report to Congress by January 1, 2007. The report should include information on the percentage of costs for prescription drugs directly advertised to consumers that are passed on to Federal agencies, the 25 most frequently prescribed and costly drugs advertised to consumers purchased or reimbursed by Federal agencies, and the total amount spent by drug manufacturers on consumer advertising. The report to Congress by January 1, 2007, must include details on prescription drugs directly advertised to consumers, costs to Federal agencies, utilization data, and recommendations for legislative or administrative actions. The report to Congress by January 1, 2007, must include recommendations for reducing Federal payments for prescription drugs directly advertised to consumers, strategies for ensuring prescription drug utilization is based on health needs, and any other appropriate legislative or administrative actions as determined by the Secretary. Definitions include the meaning of \"directly advertised to consumers\" as per the Social Security Act. The term \"Federal agency and program\" refers to specific agencies and programs outlined in section 3(b), including the Medicare program. The term \"manufacturer\" is defined in specific sections of the Social Security Act and Title 38 of the United States Code."
}